MDNA11

1 clinical trials involving this therapy/drug

This is not medical advice - consult your oncologist

Descriptions are automatically translated with AI assistance. Always verify details in the original on ClinicalTrials.gov and consult your treating physician.

RecruitingPhase I/IIBreast cancerLung cancerOvarian cancerCervical cancerColorectal cancerGastric cancerPancreatic cancerMelanomaKidney cancerBladder cancerHead and neck cancerOther cancersTriple negative (TNBC)Metastatic / advanced

A Beta-only IL-2 ImmunoTherapY Study

NCT05086692ClinicalTrials.gov ↗

This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of anti-tumor activity of MDNA11 alone or in combination with a checkpoint inhibitor in patients with advanced solid tumors.

Full details →

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.